Silence Therapeutics plc (SLNCF)
USD 0.5
(-34.21%)
USD 0.5
(-34.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 25.37 Million | 17.5 Million | 12.41 Million | 5.47 Million | 244 Thousand | - |
| Cost of Revenue | 10.31 Million | 10.88 Million | 7.45 Million | 3.76 Million | - | 508.16 Thousand |
| Gross Profit | 15.05 Million | 6.62 Million | 4.95 Million | 1.71 Million | 244 Thousand | -508.16 Thousand |
| Operating Expenses | 64.66 Million | 55.21 Million | 50.77 Million | 37.56 Million | 22.97 Million | 20.57 Million |
| Selling, General and Administrative Expenses | 20.63 Million | 19.6 Million | 20 Million | 13.98 Million | 9.64 Million | 10.82 Million |
| Research and Development Expenses | 44.02 Million | 35.6 Million | 30.76 Million | 20.2 Million | 13.33 Million | 9.74 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 74.97 Million | 66.09 Million | 58.22 Million | 41.32 Million | 22.97 Million | 20.57 Million |
| Operating Income | -49.6 Million | -48.59 Million | -45.81 Million | -35.84 Million | -22.73 Million | -20.56 Million |
| Interest Expense | 34 Thousand | 47 Thousand | 8000.00 | 16 Thousand | 33 Thousand | - |
| Income Tax Expense | -7.04 Million | -6.87 Million | -6.44 Million | -3.49 Million | -3.28 Million | -2.11 Million |
| Earnings before Tax | -50.31 Million | -47.36 Million | -45.85 Million | -36.04 Million | -22.87 Million | -20.52 Million |
| Net Income | -43.26 Million | -40.48 Million | -39.41 Million | -32.54 Million | -19.58 Million | -18.41 Million |
| Earnings Per Share Basic | -1.17 | -1.26 | -1.33 | -1.19 | -0.78 | -0.79 |
| Earnings Per Share Diluted | -1.17 | -1.26 | -1.33 | -1.19 | -0.78 | -0.79 |
| Weighted Average Shares Outstanding | 37.09 Million | 32.19 Million | 29.65 Million | 27.25 Million | 25.04 Million | 23.43 Million |
| Weighted Average Shares Outstanding (Diluted) | 37.09 Million | 32.19 Million | 29.65 Million | 27.25 Million | 25.04 Million | 23.43 Million |
| Gross Margin | 0.59 | 0.38 | 0.40 | 0.31 | 1.00 | - |
| EBIT Margin | -1.96 | -2.74 | -3.66 | -6.43 | -91.09 | - |
| Profit Margin | -1.71 | -2.31 | -3.17 | -5.94 | -80.25 | - |
| EBITDA | -49.77 Million | -47.88 Million | -45.42 Million | -35.52 Million | -22.35 Million | -20.13 Million |
| Earnings Before Tax Margin | -1.95 | -2.78 | -3.69 | -6.54 | -93.17 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 598 Thousand | 12.4 Million | 25.37 Million | 2.09 Million | 2.79 Million | 9.1 Million |
| Cost of Revenue | 2.63 Million | 2.21 Million | 10.31 Million | 1.34 Million | 1.6 Million | 2.83 Million |
| Gross Profit | -2.04 Million | 10.19 Million | 15.05 Million | 753 Thousand | 1.19 Million | 6.27 Million |
| Operating Expenses | 16.28 Million | 14.34 Million | 64.66 Million | 14.05 Million | 13.89 Million | 17.73 Million |
| Selling, General and Administrative Expenses | 5.28 Million | 5.17 Million | - | 4.11 Million | 4.95 Million | 5.11 Million |
| Research and Development Expenses | 10.99 Million | 9.17 Million | - | 9.93 Million | 8.93 Million | 12.61 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 18.92 Million | 16.56 Million | 74.97 Million | 15.39 Million | 15.49 Million | 20.56 Million |
| Operating Income | -18.32 Million | -4.15 Million | -49.6 Million | -13.29 Million | -12.69 Million | -11.45 Million |
| Interest Expense | 183 Thousand | 13 Thousand | 34 Thousand | -63 Thousand | 8000.00 | 893 Thousand |
| Income Tax Expense | -1.87 Million | -1.48 Million | -7.04 Million | -554 Thousand | -2.41 Million | -1.6 Million |
| Earnings before Tax | -17.44 Million | -3.36 Million | -50.31 Million | -14.96 Million | -10.66 Million | -12.01 Million |
| Net Income | -19.63 Million | -1.87 Million | -43.26 Million | -14.41 Million | -8.25 Million | -10.4 Million |
| Earnings Per Share Basic | -0.42 | -0.04 | - | -0.37 | -0.22 | -0.29 |
| Earnings Per Share Diluted | -0.42 | -0.04 | - | -0.37 | -0.22 | -0.29 |
| Weighted Average Shares Outstanding | 46.73 Million | 43.96 Million | 37.09 Million | 38.92 Million | 37.3 Million | 36.16 Million |
| Weighted Average Shares Outstanding (Diluted) | 46.73 Million | 43.96 Million | 37.09 Million | 38.92 Million | 37.3 Million | 36.16 Million |
| Gross Margin | -3.41 | 0.82 | 0.59 | 0.36 | 0.43 | 0.69 |
| EBIT Margin | -28.66 | -0.26 | - | -7.10 | -3.76 | -1.21 |
| Profit Margin | -32.83 | -0.15 | -1.71 | -6.87 | -2.95 | -1.14 |
| EBITDA | -17.13 Million | -3.23 Million | - | -14.9 Million | -10.52 Million | -10.99 Million |
| Earnings Before Tax Margin | -30.64 | -0.33 | -1.95 | -6.34 | -4.54 | -1.26 |
1038
603658
MSTO
DWS
6217
BBRRF